SCHEMBL8669199

SCHEMBL8669199

COc1ccc2c(c1)N(C)C(=O)C2C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 8/20 0.56
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
KYAT1 Q16773 1/20 0.41
KYAT3 Q6YP21 1/20 0.41
AADAT Q8N5Z0 1/20 0.41
LMNA P02545 1/20 0.41
CNR2 P34972 1/20 0.41
CCL2 P13500 7/20 0.40
MGLL Q99685 1/20 0.40
SRD5A1 P18405 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
TTR P02766 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8532730 0.87 BRD4 (0.52) BRD4ALDH1A1MAPTKYAT1KYAT3
SCHEMBL19657303 0.77 HSD17B10 (0.38) BRD4AADATLMNACCL2MGLL
SCHEMBL19657298 0.77 HSD17B10 (0.38) BRD4AADATLMNACCL2MGLL
SCHEMBL30984391 0.77 HSD17B10 (0.38) BRD4AADATLMNACCL2MGLL
SCHEMBL10695734 0.76 TNKS2 (0.48) BRD4ALDH1A1MAPT
SCHEMBL26688764 0.76 GRIA1 (0.37) BRD4ALDH1A1SRD5A1
SCHEMBL19644092 0.76 MEN1 (0.47) BRD4ALDH1A1LMNACCL2MGLL
SCHEMBL29704482 0.76 MEN1 (0.47) BRD4ALDH1A1LMNACCL2MGLL
SCHEMBL8667942 0.76 EGFR (0.36) BRD4MAPTCCL2
SCHEMBL25295086 0.75 CYP2A6 (0.38) BRD4ALDH1A1MAPTCCL2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5260452-A 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-11-09 US claimed
US-5726323-A COMPOUNDS USEFUL FOR ALLEVIATING MEMORY DYSFUNCTIONS HOECHST MARION ROUSSEL, INC. 1998-03-10 US disclosed
US-5591864-A CHEMICAL INTERMEDIATES FOR COMPOUNDS WHICH ALLEVIATE MEMORY DYSFUNCITONS HOECHST MARION ROUSSEL, INC. (US) 1997-01-07 US disclosed
EP-0484573-B1 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-03-13 EP disclosed
US-5260452-A 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-11-09 US disclosed
EP-0484573-A1 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-05-13 EP disclosed
US-5081117-A Treatment of memory dysfunctions such as in Alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-01-14 US disclosed